Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002914068 | SCV003257406 | likely benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002914067 | SCV003622089 | uncertain significance | Inborn genetic diseases | 2021-10-26 | criteria provided, single submitter | clinical testing | The c.1880A>G (p.Q627R) alteration is located in exon 12 (coding exon 12) of the INTU gene. This alteration results from a A to G substitution at nucleotide position 1880, causing the glutamine (Q) at amino acid position 627 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003961202 | SCV004774466 | likely benign | INTU-related disorder | 2022-05-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |